ATYR vs ECL · rev $235.0K vs P/E 35, rev $4.01B
aTyr Pharma, Inc. (ATYR) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
aTyr Pharma, Inc. (ATYR) is a biotechnology company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported ATYR revenue for 2024-12-31 was $235.0K. Net income was -$64.0M. Revenue was down 33.4% from 2023-12-31 to 2024-12-31. ATYR currently screens at market cap $471.7M.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
ATYR currently screens at market cap $471.7M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the ATYR and ECL stock pages for the full models.
Not investment advice.